MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 141 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,397,300 | -33.9% | 57,500 | +4.5% | 2.76% | -34.1% |
| Q2 2023 | $12,705,000 | +74.8% | 55,000 | +83.3% | 4.19% | +95.3% |
| Q1 2023 | $7,268,000 | +25.2% | 30,000 | +50.0% | 2.15% | -13.3% |
| Q4 2022 | $5,805,000 | +257.2% | 20,000 | -20.0% | 2.48% | +443.4% |
| Q3 2022 | $1,625,000 | +1508.9% | 25,000 | +2677.8% | 0.46% | +1132.4% |
| Q4 2018 | $101,000 | -96.7% | 900 | -93.7% | 0.04% | -94.3% |
| Q3 2018 | $3,041,000 | -53.7% | 14,200 | -39.6% | 0.65% | -66.6% |
| Q2 2018 | $6,573,000 | – | 23,500 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |